Herb-drug interaction of 50 Chinese herbal medicines on CYP3A4 activity in vitro and in vivo

American Journal of Chinese Medicine

Volumn 40, Issue 1, 2012, Pages 57-73

  Pao, Li Heng ^a   Hu, Oliver Yoa Pu ^a   Fan, Hsien Yuan ^a   Lin, Chang Ching ^a   Liu, Liang Chun ^a   Huang, Pei Wei ^a  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

Author keywords

Chinese Herbal Medicine; CYP3A4; Herb Drug Interaction; Pharmacokinetics

Indexed keywords

6BETA HYDROXYTESTOSTERONE; ACHYRANTHES BIDENTATA EXTRACT; ANGELICA SINENSIS EXTRACT; ASTRAGALUS MEMBRANACEUS EXTRACT; ATRACTYLODES EXTRACT; CINNAMOMUM CASSIA EXTRACT; CODONOPSIS PILOSULA EXTRACT; CRATAEGUS EXTRACT; CYTOCHROME P450 3A4; EUCOMMIA ULMOIDES EXTRACT; GARDENIA JASMINOIDES EXTRACT; LIGUSTICUM CHUANXIONG EXTRACT; LIGUSTRUM LUCIDUM EXTRACT; LONICERA JAPONICA EXTRACT; MAGNOLIA OFFICINALIS EXTRACT; MIDAZOLAM; MULBERRY EXTRACT; OPHIOPOGON ROOT; PAEONIA LACTIFLORA EXTRACT; PAEONIA SUFFRUTICOSA EXTRACT; PINELLIA EXTRACT; POLYGONATUM EXTRACT; PORIA COCOS EXTRACT; PRUNELLA VULGARIS EXTRACT; PRUNUS EXTRACT; SCUTELLARIA BAICALENSIS EXTRACT; SOUR ORANGE EXTRACT; TESTOSTERONE DERIVATIVE; TRICHOSANTHES EXTRACT; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ACHYRANTHES; ALISMA; ANGELICA SINENSIS; ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; ASTRAGALUS MEMBRANACEUS; ATRACTYLODES; CHINESE MEDICINE; CINNAMOMUM CASSIA; CODONOPSIS PILOSULA; CONTROLLED STUDY; CRATAEGUS; CYATHULA OFFICINALIS; DRUG ANTAGONISM; DRUG METABOLISM; DRUG SCREENING; ENZYME ACTIVITY; EUCOMMIACEAE; GARDENIA; HERBAL MEDICINE; LEGUME; LIGUSTICUM CHUANXIONG; LIGUSTRUM; LIQUID CHROMATOGRAPHY; LIVER MICROSOME; LONICERA JAPONICA; MAGNOLIA BIONDII; MAGNOLIACEAE; MALE; MAXIMUM PLASMA CONCENTRATION; MULBERRY; NONHUMAN; PINELLIA; POLYGONATUM ODORATUM; PORIA; PRUNELLA; PRUNUS; RAT; SCUTELLARIA BAICALENSIS; SOUR ORANGE; SPATHOLOBUS SUBERECTUS; TANDEM MASS SPECTROMETRY; TRICHOSANTHES;

ANGIOSPERMS; ANIMALS; ASTRAGALUS PLANT; CYTOCHROME P-450 CYP3A; DRUGS, CHINESE HERBAL; FABACEAE; HERB-DRUG INTERACTIONS; HUMANS; MAGNOLIA; MALE; MICROSOMES, LIVER; PAEONIA; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY; SCUTELLARIA BAICALENSIS;

EID: 84863057043     PISSN: 0192415X     EISSN: None     Source Type: Journal    
DOI: 10.1142/S0192415X1250005X     Document Type: Article

References (44)

1. Anzenbacher, P. and E. Anzenbacherova. Cytochromes P450 and metabolism of xenobiotics. Cell Mol. Life Sci. 58: 737-747, 2001. (Pubitemid 32553031)
2. Arellano, C., C. Philibert, O. Lacombe, J. Woodley and G. Houin. Liquid chromatographic-mass spectrometric method to assess cytochrome P450-mediated metabolism of testosterone by rat everted gut sacs. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 807: 263-270, 2004. (Pubitemid 38759992)
3. Bailey, D., J. Malcolm, O. Arnold and J. Spence. Grapefruit juice - drug interactions. Br. J. Clin. Pharmacol. 46: 101-110, 1998.
4. Brazier, N. and M. Levine, Drug-herb interaction among commonly used conventional medicines: a compendium for health care professionals. Am. J. Ther. 10: 163-169, 2003.
5. Brownie, S. and M. Rolfe. Health characteristics of older Australian dietary supplement users compared to non-supplement users. Asia Pac. J. Clin. Nutr. 13: 365-371, 2004. (Pubitemid 40064067)
6. Bruno, J. and J. Ellis. Herbal use among US elderly: 2002 National health interview survey. Ann. Pharmacother. 39: 643-648, 2005. (Pubitemid 40396617)
7. Clement, Y., A. Williams, K. Khan, T. Bernard, S. Bhola, M. Fortuné, O. Medupe, K. Nagee and C. Seaforth. A gap between acceptance and knowledge of herbal remedies by physicians: the need for educational intervention. BMC Complement. Altern. Med. 5: 1-9, 2005.
8. Dhananjay, P. and K. Ashim, MDR- and CYP3A4-mediated drug-herbal interactions. Life Sci. 78: 2131-2145, 2006.
9. Ernst, E. and M. Pittler, Risks associated with herbal medicinal products. Wien. Med. Wochenschr. 152: 183-189, 2002. (Pubitemid 34494248)
10. Evans, A. Influence of dietary components on the gastrointestinal metabolism and transport of drugs. Ther. Drug Monit. 22: 131-136, 2000. (Pubitemid 30083114)
11. FDA, Guidance for Industry. In Vivo Drug Metabolism/Drug Interaction Studien - Study Design, Data Analysis, and Recommendations for Dosing and Labeling, 1999.
12. Friedrich, G., T. Rose and K. Rissler. Determination of testosterone metabolites in human hepato-cytes. I. Development of an on-line sample preparation liquid chromatography technique and mass spectroscopic detection of 6beta-hydroxytestosterone. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 784: 49-61, 2003. (Pubitemid 36009340)
13. Fugh-Berman, A., Herb-drug interactions. Lancet 355: 134-138, 2000. (Pubitemid 30068565)
14. Galetin, A., K. Ito, D. Hallifax and J. Houston. CYP3A4 substrate selection and substitution in the prediction of potential drug-drug interactions. J. Pharmacol. Exp. Ther. 314: 180-190, 2005. (Pubitemid 41058254)
15. Garcia, M., D. Ma, A. Dicioccio and J. Cali. The use of a high-throughput luminescent method to assess CYP3A enzyme induction in cultured rat hepatocytes. In Vitro Cell Dev. Biol. Anim. 44: 129-134, 2008.
16. Guengerich, P. Human cytochrome P450 enzymes. In: P.R. Ortiz de Montellano (ed.), Cytochrome P450: Structure, Mechanism and Biochemistry. Plenum Press Publication, New York, 1995, pp. 473-535.
17. Harrison, R., D. Holt, D. Pattison and P. Elton. Who and how many people are taking herbal supplements? A survey of 21,923 adults. Int. J. Vitam. Nutr. Res. 74: 183-186, 2004. (Pubitemid 38915587)
18. Hyodo, I., K. Eguchi, T. Nishina, H. Endo, M. Tanimizu, I. Mikami, S. Takashima and J. Imanishi. Perceptions and attitudes of clinical oncologists on complementary and alternative medicine, a nationwide survey in Japan. Cancer 97: 2861-2868, 2003. (Pubitemid 36605156)
19. Ioannides, C. Pharmacokinetic interactions between herbal remedies and medicinal drugs. Xeno-biotica 32: 451-478, 2002. (Pubitemid 34743619)
20. Iwase, M., N. Kurata, R. Ehana, Y. Nishimura, T. Masamoto and H. Yasuhara. Evaluation of the effects of hydrophilic organic solvents on CYP3A-mediated drugdrug interaction in vitro. Hum. Exp. Toxicol. 25: 715-721, 2006. (Pubitemid 46101697)
21. Izzo, A. and E. Ernst, Interactions between herbal medicines and prescribed drugs: a systematic review. Drugs 61: 2163-2175, 2001. (Pubitemid 34074799)
22. Kenworthy, K., J. Bloomer, S. Clarke and J. Houston. CYP3A4 drug interactions: correlation of 10 in vitro probe substrates. Br. J. Clin. Pharmacol. 48: 716-727, 1999. (Pubitemid 29520596)
23. Kim, H.K., S.S. Baek and H.Y. Cho. Inhibitory effect of pomegranate on intestinal sodium dependent glucose uptake. Am. J. Chin. Med. 39: 1015-1027, 2011.
24. Klepser, T. and M. Klepser. Unsafe and potentially safe herbal therapies. Am. J. Health Syst. Pharm. 56: 125-138, 1999. (Pubitemid 29052733)
25. Lowry, O., N. Rosebrough, A. Farr and R. Randall. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275, 1951.
26. Paine, M., M. Khalighi, J. Fisher, D. Shen, K. Kunze, C. Marsh, J. Perkins and K. Thummel. Characterization of interintestinal and intraintestinal variations in human CYP3A-dependent metabolism. J. Pharmacol. Exp. Ther. 283: 1552-1562, 1997. (Pubitemid 28016533)
27. Peng, C., P. Glassman, L. Trilli, J. Hayes-Hunter and C. Good. Incidence and severity of potential drug-dietary supplement interactions in primary care patients: an exploratory study of 2 outpatient practices. Arch. Inter. Med. 164: 630-636, 2004. (Pubitemid 38392977)
28. Puig, J. and T. Tephly, Isolation and purification of rat liver morphine UDP-glucuronosyltransferase. Mol. Pharmacol. 30: 558-565, 1986. (Pubitemid 17228899)
29. Risberg, T., A. Kolstad, A. Johansen and K. Vingerhagen. Opinions on and use of alternative medicine among physicians, nurses and clerks in northern Norway. In Vivo 13: 493-498, 1999. (Pubitemid 30189194)
30. Sardesai, V. Herbal medicines: poisons or potions? J. Lab. Clin. Med. 139: 343-348, 2002. (Pubitemid 34604655)
31. Shimada, T., M. Mimura, K. Inoue, S. Nakamura, H. Oda, S. Ohmori and H. Yamazaki. Cytochrome P450-dependent drug oxidation activities in liver microsomes of various animal species including rats, guinea pigs, dogs, monkeys, and humans. Arch. Toxicol. 71: 401-408, 1997. (Pubitemid 27214472)
32. Stresser, D., A. Blanchard, S. Turner, J. Erve. A. Dandeneau, V. Miller and C. Crespi. Substrate-dependent modulation of CYP3A4 catalytic activity: analysis of 27 test compounds with four fluorometric substrates. Drug Metab. Dispos. 28: 1440-1448, 2000.
33. Stupay, S. and L. Siversten. Herbal and nutritional supplement use in the elderly. Nurse Pract. 25: 56-60, 2000.
34. Thummel, K. and G. Wilkinson. In vitro and in vivo drug interactions involving human CYP3A. Ann. Rev. Pharmacol. Toxicol. 38: 389-430, 1998. (Pubitemid 28231501)
35. Wang, R., D. Newton, T. Scheri and A. Lu. Human cytochrome P450 3A4-catalyzed testosterone 6b-hydroxylation and erythromycin N-demethylation. Competition during catalysis. Drug Metab. Dispos. 25: 502-507, 1997. (Pubitemid 27209375)
36. Watkins, P., S. Wrighton, E. Schuetz, D. Molowa and P. Guzelian. Identification of glucocorticoid-inducible cytochromes P-450 in the intestinal mucosa of rats and man. J. Clin. Invest. 80: 1029-1036, 1987. (Pubitemid 18075638)
37. WHO, World Health Organization. WHO Traditional Medicine Strategy 2002-2005. WHO, 2002.
38. Wilkinson, G. The effects of diet, aging and disease-states on presystemic elimination and oral drug bioavailability in humans. Adv. Drug Deliv. Rev. 27: 129-159, 1997. (Pubitemid 27417870)
39. Williamson, E. Drug interactions between herbal and prescription medicines. Drug Saf. 26: 1075-1092, 2003. (Pubitemid 38021390)
40. Wrighton, S. and J. Stevens. The human hepatic cytochromes P450 involved in drug metabolism. Crit. Rev. Toxicol. 22: 1-21, 1992.
41. Xu, B., M. Ishii, L. Ding, N. Fischer and T. Inaba. Interaction of serum proteins with CYP isoforms in human liver microsomes: inhibitory effects of human and bovine albumin, alpha-globulins, alpha-1-acid glycoproteins and gamma-globulins on CYP2C19 and CYP2D6. Life Sci. 72: 1953-1962, 2003. (Pubitemid 36207532)
42. Yang, C., J. Brady and J. Hong. Dietary effects on cytochromes P450, xenobiotic metabolism, and toxicity. FASEB J. 6: 737-744, 1992.
43. Yuan, R., S. Madani, X. Wei, K. Reynolds and S. Huang. Evaluation of cytochrome P450 probe substrates commonly used by the pharmaceutical industry to study in vitro drug interactions. Drug Metab. Dispos. 30: 1311-1319, 2002. (Pubitemid 35397032)
44. Zhou, S., Drugs behave as substrates, inhibitors and inducers of human cytochrome P450 3A4. Curr. Drug Metab. 9: 310-322, 2008. (Pubitemid 351836420)